Annual Total Liabilities
$96.33 M
-$93.09 M-49.14%
December 31, 2023
Summary
- As of February 7, 2025, MDXG annual total liabilities is $96.33 million, with the most recent change of -$93.09 million (-49.14%) on December 31, 2023.
- During the last 3 years, MDXG annual total liabilities has fallen by -$105.85 million (-52.35%).
- MDXG annual total liabilities is now -52.35% below its all-time high of $202.18 million, reached on December 31, 2020.
Performance
MDXG Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$62.88 M
+$740.00 K+1.19%
September 30, 2024
Summary
- As of February 7, 2025, MDXG quarterly total liabilities is $62.88 million, with the most recent change of +$740.00 thousand (+1.19%) on September 30, 2024.
- Over the past year, MDXG quarterly total liabilities has dropped by -$3.07 million (-4.65%).
- MDXG quarterly total liabilities is now -68.90% below its all-time high of $202.18 million, reached on December 31, 2020.
Performance
MDXG Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MDXG Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.1% | -4.7% |
| 3 y3 years | -52.4% | -65.4% |
| 5 y5 years | +31.6% | -52.6% |
MDXG Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.1% | at low | -67.3% | +1.2% |
| 5 y | 5-year | -52.4% | at low | -68.9% | +1.2% |
| alltime | all time | -52.4% | >+9999.0% | -68.9% | >+9999.0% |
MiMedx Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $62.88 M(+1.2%) |
| Jun 2024 | - | $62.14 M(-5.8%) |
| Mar 2024 | - | $65.95 M(-31.5%) |
| Dec 2023 | $96.33 M(-49.1%) | $96.33 M(-48.7%) |
| Sep 2023 | - | $187.69 M(-0.7%) |
| Jun 2023 | - | $189.04 M(+1.6%) |
| Mar 2023 | - | $186.10 M(-1.7%) |
| Dec 2022 | $189.42 M(+0.8%) | $189.42 M(-1.5%) |
| Sep 2022 | - | $192.32 M(+5.5%) |
| Jun 2022 | - | $182.27 M(+0.2%) |
| Mar 2022 | - | $181.88 M(-3.2%) |
| Dec 2021 | $187.85 M(-7.1%) | $187.85 M(+0.8%) |
| Sep 2021 | - | $186.33 M(-4.1%) |
| Jun 2021 | - | $194.28 M(-2.3%) |
| Mar 2021 | - | $198.86 M(-1.6%) |
| Dec 2020 | $202.18 M(+52.3%) | $202.18 M(+0.9%) |
| Sep 2020 | - | $200.45 M(+56.5%) |
| Jun 2020 | - | $128.05 M(-0.4%) |
| Mar 2020 | - | $128.57 M(-3.2%) |
| Dec 2019 | $132.77 M(+81.4%) | $132.77 M(-5.0%) |
| Sep 2019 | - | $139.69 M(-4.1%) |
| Jun 2019 | - | $145.63 M(+110.8%) |
| Mar 2019 | - | $69.09 M(-5.6%) |
| Dec 2018 | $73.19 M(+54.2%) | $73.19 M(+54.2%) |
| Dec 2017 | $47.46 M(-21.2%) | $47.46 M(+31.0%) |
| Sep 2017 | - | $36.23 M(-31.1%) |
| Jun 2017 | - | $52.59 M(-11.5%) |
| Mar 2017 | - | $59.45 M(-1.3%) |
| Dec 2016 | $60.26 M(+115.8%) | $60.26 M(+3.2%) |
| Sep 2016 | - | $58.39 M(+5.3%) |
| Jun 2016 | - | $55.45 M(-12.0%) |
| Mar 2016 | - | $62.98 M(+125.5%) |
| Dec 2015 | $27.93 M | $27.93 M(+9.9%) |
| Sep 2015 | - | $25.41 M(+23.3%) |
| Jun 2015 | - | $20.60 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $19.70 M(-1.1%) |
| Dec 2014 | $19.93 M(+79.1%) | $19.93 M(+24.1%) |
| Sep 2014 | - | $16.06 M(+39.2%) |
| Jun 2014 | - | $11.54 M(+3.8%) |
| Mar 2014 | - | $11.11 M(-0.1%) |
| Dec 2013 | $11.13 M(-26.7%) | $11.13 M(+14.0%) |
| Sep 2013 | - | $9.76 M(+32.0%) |
| Jun 2013 | - | $7.39 M(+18.1%) |
| Mar 2013 | - | $6.26 M(-58.8%) |
| Dec 2012 | $15.18 M(-0.2%) | $15.18 M(+5.7%) |
| Sep 2012 | - | $14.35 M(+21.6%) |
| Jun 2012 | - | $11.80 M(-17.8%) |
| Mar 2012 | - | $14.36 M(-5.5%) |
| Dec 2011 | $15.20 M(+1114.3%) | $15.20 M(+29.9%) |
| Sep 2011 | - | $11.70 M(+3.0%) |
| Jun 2011 | - | $11.36 M(+2.9%) |
| Mar 2011 | - | $11.04 M(+781.7%) |
| Dec 2010 | $1.25 M(-65.4%) | $1.25 M(+9.5%) |
| Sep 2010 | - | $1.14 M(-9.3%) |
| Jun 2010 | - | $1.26 M(+35.9%) |
| Mar 2010 | - | $928.10 K(-80.8%) |
| Dec 2009 | $3.62 M(-33.7%) | - |
| Sep 2009 | - | $4.83 M(-37.4%) |
| Jun 2009 | - | $7.71 M(+41.2%) |
| Mar 2009 | - | $5.46 M(+23.4%) |
| Mar 2009 | $5.46 M(+475.7%) | - |
| Dec 2008 | - | $4.43 M(+25.3%) |
| Sep 2008 | - | $3.53 M(+319.8%) |
| Jun 2008 | - | $841.90 K(+2251.7%) |
| Mar 2008 | $948.50 K(+2549.4%) | - |
| Dec 2007 | $35.80 K(+237.7%) | $35.80 K(+23.4%) |
| Sep 2007 | - | $29.00 K(-20.5%) |
| Jun 2007 | - | $36.50 K(+100.5%) |
| Mar 2007 | - | $18.20 K |
| Dec 2006 | $10.60 K | - |
FAQ
- What is MiMedx annual total liabilities?
- What is the all time high annual total liabilities for MiMedx?
- What is MiMedx annual total liabilities year-on-year change?
- What is MiMedx quarterly total liabilities?
- What is the all time high quarterly total liabilities for MiMedx?
- What is MiMedx quarterly total liabilities year-on-year change?
What is MiMedx annual total liabilities?
The current annual total liabilities of MDXG is $96.33 M
What is the all time high annual total liabilities for MiMedx?
MiMedx all-time high annual total liabilities is $202.18 M
What is MiMedx annual total liabilities year-on-year change?
Over the past year, MDXG annual total liabilities has changed by -$93.09 M (-49.14%)
What is MiMedx quarterly total liabilities?
The current quarterly total liabilities of MDXG is $62.88 M
What is the all time high quarterly total liabilities for MiMedx?
MiMedx all-time high quarterly total liabilities is $202.18 M
What is MiMedx quarterly total liabilities year-on-year change?
Over the past year, MDXG quarterly total liabilities has changed by -$3.07 M (-4.65%)